House Sustains Veto of Stem Cell Bill The House sustained President Bush's first-ever veto of a bill to expand federal funding of embryonic stem cell research. But backers of the bill say that the politics of the measure will favor them in the end.
NPR logo

House Sustains Veto of Stem Cell Bill

  • Download
  • <iframe src="" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
House Sustains Veto of Stem Cell Bill

House Sustains Veto of Stem Cell Bill

House Sustains Veto of Stem Cell Bill

  • Download
  • <iframe src="" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The House sustained President Bush's first-ever veto of a bill to expand federal funding of embryonic stem cell research. But backers of the bill say that the politics of the measure will favor them in the end.


President Bush was victorious in this week's fight over embryonic stem cell research. The House, last night, failed to override the first veto of the Bush presidency. That means there won't be any loosening of the limits on federal research funding that the president imposed five years ago.

But as NPR's Julie Rovner reports, those who voted in support of stem cell research remain confident they'll prevail in the end.

JULIE ROVNER reporting:

The president wasted no time making good on his veto threat against the bill passed by the House last year and the Senate Tuesday night.

President GEORGE W. BUSH: This bill would support the taking of innocent human life in the hope of finding medical benefits for others. It crosses a moral boundary that our decent society needs to respect, so I vetoed it.

ROVNER: The measure would have expanded the number of cell lines eligible for federal funding, but only if they're from embryos left over in fertility clinics. To back up his point that every embryo is a potential person, Mr. Bush announced his actions surrounded by so-called snowflake children, who were adopted as embryos from that same excess fertility clinic supply.

The House wasted no time responding to the president. It debated and failed to override the veto less than three hours later. Backers of the bill like Massachusetts Democratic Ed Markey complained that the president's action will turn back the clock on research that scientists say shows promise in treating or curing dozens of chronic and fatal afflictions.

Representative ED MARKEY (Democrat, Massachusetts): This will be remembered as a luddite moment in American history, when scientific progress was brought to a halt by those who put fear ahead of hope and ideology ahead of science.

ROVNER: But enough members backed the president to sustain his first veto. They included House majority leader John Boehner.

Representative JOHN BOEHNER (Republican, Ohio; House Majority Leader): No just society should condone the destruction of innocent life, even in the name of medical research. The president was right to veto this bill. It would be wrong for this House to overrule the president's decision.

ROVNER: Even with no policy change, though, Democrats are already predicting they can turn this defeat into victory in the November mid-term elections. It's already become an issue in several states with potentially vulnerable Republicans, including Missouri. New York senator Chuck Schumer heads the Senate Democrat's campaign committee.

Senator CHARLES SCHUMER (Democrat, New York): Democracy is all about accountability, and there's going to be accountability in this issue.

ROVNER: Schumer says the reason is simple. Polls show a large majority of the public supports expanding embryonic stem cell research.

Sen. SCHUMER: Everyone knows someone who needs this bill. Everyone knows someone who has a child with juvenile diabetes. Everyone knows someone who has a parent with Alzheimer's or Parkinson's, so we don't have to do much work on this. It's going to speak for itself.

ROVNER: But Republicans - even those who support expanding the research - say Democrats are overstating the impact of the debate. New Hampshire Republican Congressman Charlie Bass says Democrats claim just about every issue will help them.

Representative CHARLES BASS (Republican, New Hampshire): It's inappropriate to try to spin this issue as somehow being hurtful to Republicans in November across the board, because it won't be. It might hurt the president's popularity, but I would suggest that he's not on the ballot in November. So therefore, that's not really relevant.

ROVNER: The Senate, meanwhile - where Majority Leader Bill Frist broke with both the president and the Republican conservative base to support the stem cell bill - today is scheduled to take up a bill much more to conservatives' liking. It would make it a crime to take a minor across state lines for an abortion if the girl's home state has a parental notification or consent law.

The House has passed the bill several times, most recently a version in April of 2005. The Senate, however, has never fully debated the measure. Opponents say the timing of this first Senate vote in nearly eight years is no coincidence.

Julie Rovner, NPR News, Washington.

Copyright © 2006 NPR. All rights reserved. Visit our website terms of use and permissions pages at for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.

Stem Cell Research: How the States Stand

Researcher Jonathan Clarke holds up human embryonic stem-cell cultures in La Jolla, Cali. In 2004, Californians approved Proposition 71, which allows the state to sell bonds to fund embryonic stem-cell research. Sandy Huffaker /Getty Images hide caption

toggle caption
Sandy Huffaker /Getty Images

As the debate heats up in the U.S. Senate this week over funding for stem-cell research, some states have developed their own plans.

Current federal law does not ban embryonic stem-cell research, but it does restrict funding to studies on a limited number of stem cell-lines created before August 2001. The situation varies at the state level. Some states restrict the use of embryonic stem cells from some or all sources, while others actively promote such research.

Here's how the debate is playing out in several states:

California: In the fall of 2004, California voters approved Proposition 71, which authorizes the state to sell $3 billion in bonds to fund embryonic stem-cell research over a 10-year span.

The measure bans reproductive cloning, but specifically permits so-called therapeutic cloning, which scientists prefer to call "somatic cell nuclear transfer." The process involves the transplantation of DNA from an adult cell into an unfertilized egg in order to grow embryonic stem cells.

But the proposition is in legal limbo. Lawsuits have hampered the ability of the California Institute for Regenerative Medicine, the stem-cell institute created by Proposition 71, to support research. The agency has only managed to award about $12 million in training grants thus far.

This April, Superior Court Judge Bonnie Sabraw upheld the constitutionality of the state’s stem-cell program. Appeals by taxpayer groups and those ethically opposed to stem-cell research are expected to take months to play out.

Connecticut: In June 2005, Connecticut Gov. Jodi Rell signed legislation that will provide $100 million in funding over a 10-year span for adult and embryonic stem-cell research in the state. The state's stem-cell research program announced its intention to fund as much as $20 million in research projects this year.

Delaware: In June 2005, the Delaware Senate approved a bill that would allow embryonic stem cells to be used for research. Embryos available for research would be limited to those considered "surplus" by fertility clinics. Written consent would be required from the couple that created the embryo. The sale of embryos would be outlawed. The bill also requires the formation of an 11-member panel to set up guidelines to govern research.

The Delaware House put the bill on hold in late June 2005. In January 2006, it voted to pass an amended version of the bill that removed the original language about imposing research guidelines and regulations. The new version must now return to the Senate for consideration.

Florida: Currently, the Florida House and Senate are considering bills that would provide $150 million in state funding for stem-cell research over 10 years. If passed, the bill would allow embryos discarded by in vitro fertilization clinics to be used for research. But the outlook is uncertain. Some legislators in Florida, including Gov. Jeb Bush, have been very vocal about their opposition to stem-cell research.

Petitions are under way to place two different constitutional amendments on the 2008 ballot. One petition is a pro-research ballot measure sponsored by Floridians for Stem Cell Research and Cures. The petition calls for $200 million over a period of 10 years in government-funded grants to conduct embryonic stem-cell research. The other ballot measure opposes government funding for such research; it's sponsored by a mortgage broker in Boca Raton.

Illinois: In July 2005, Democratic Gov. Rod Blagojevich bypassed the Illinois state legislature to create a stem-cell research institute by executive order. Blagojevich announced that the research would come through a line item in the state budget that gave the Public Health Department $10 million to fund research — a surprise move that drew criticism from opponents. In April, the governor allocated the funds in 10 grants to area institutions.

Maryland: In March, the state legislature passed a bill approving state funding for embryonic stem-cell research. The bill creates a state-appointed panel that will authorize and award grants based on annual funding availability in the governor's budget. An independent, scientific peer-review committee will review applications and then forward its opinions to the state panel. Gov. Robert Ehrlich signed the bill into law in April, authorizing $15 million for research in fiscal year 2007.

Missouri: In Missouri, Republican state Sen. Matt Bartle has led a push to ban the use of a cloning procedure, called somatic cell nuclear transfer, that is used in stem-cell research. However, the state's Republican legislators are split on the issue. Anti-abortion lawmakers oppose the process because it involves the destruction of human embryos. But other Republicans, including Gov. Matt Blunt — who considers himself one of the nation's staunchest pro-life governors — support the procedure because of its potential to help treat disease.

Currently, Missouri law forbids the use of state funds for reproductive cloning, but not for cloning for the purpose of stem-cell research. Research groups in Missouri are fighting efforts to restrict stem-cell research. A voter referendum that would allow Missouri patients to receive stem-cell cures allowed under federal law is expected to appear on the November ballot.

Meanwhile, Illinois Gov. Rod Blagojevich has invited Missouri stem-cell researchers to bring their work to his state.

New Jersey: California got the headlines, but in fact the nation's first state-supported stem research institute was actually established in New Jersey in mid-2004. However, since then, efforts to make the institute a reality have largely stalled.

A referendum authorizing $230 million for stem-cell research has been delayed until November 2006 at the earliest — a year later than originally scheduled. The delay reflects, in part, fears that the measure would energize conservative voters in a year when the largely Democratic state assembly faces re-election.

In addition to the referendum, a bill that would use up to $250 million in excess cigarette-tax revenue to fund stem-cell research is moving through the legislature.

Ohio: Republican Gov. Bob Taft's "Third Frontier" program, which supports high-tech research in Ohio, including biomedical research, was initiated in 2003. As yet, none of the grants have gone toward embryonic stem-cell research.

Last summer, Taft vetoed a legislative ban on funding stem-cell research with money from the program. However, he has also issued an executive order requiring any stem-cell research funded by Third Frontier to follow the same guidelines used for federal funding. The bond program that would fund the Third Frontier program in the future is slated for the November ballot.

State Restrictions:

Arizona specifically prohibits the use of state funds for embryonic stem-cell research. Louisiana bans research on embryos created through in vitro fertilization. Michigan, Iowa, Arkansas, North Dakota and South Dakota have banned research on cloned embryos. South Dakota's law goes further, prohibiting stem-cell research on all embryos, regardless of the source.

Sources: NPR staff reports, National Conference of State Legislatures and the Associated Press.